🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir

Published 22/05/2024, 13:50
© Reuters.  Jim Cramer: This Industrial Stock Is Doing \'Very Well\'; Here\'s His Take On Palantir
PBR
-
J
-
LAZ
-
SRPT
-
ZBRA
-
WMS
-
ENB
-
PLTR
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Enbridge Inc. (NYSE:ENB). “I trust that management team,” he added.

On May 10, Enbridge posted better-than-expected quarterly earnings.

Lazard, Inc. (NYSE:LAZ) is a good buy here, Cramer said. “I do believe that things are going to get a little less onerous… when it comes to takeovers.”

On May 20, Lazard announced that Ben Braun joined the firm as managing director and global head of Media, Entertainment & Sports Advisory.

Cramer recommended staying away from AST SpaceMobile, Inc. (NASDAQ:ASTS) as there are so many great companies. “We don't need to be in that one,” he added.

On May 15, AST SpaceMobile and AT&T announced a definitive commercial agreement.

The “Mad Money” host said Advanced Drainage Systems, Inc. (NYSE:WMS) is “another incredible infrastructure play.”

On May 16, Advanced Drainage Systems posted upbeat quarterly sales.

Zebra Technologies Corporation (NASDAQ:ZBRA) has “made it all the way back. Halleluiah for them,” Cramer said.

On May 20, Zebra Technologies announced the launch of a $500 million senior unsecured note private offering.

Jacobs Solutions Inc. (NYSE:J) is doing “very well,” Cramer said. “I would want to own it.”

Last week, Jacobs announced the appointment of Venk Nathamuni as the company’s new chief financial officer, effective June 3.

“Let's stick with domestic,” Cramer said when asked about Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR).

Last week, Brazil President Luiz Inacio Lula da Silva fired Petrobras CEO following a dispute over dividend payments.

Cramer said he is not going to say no to Sarepta Therapeutics, Inc. (NASDAQ:SRPT). “It has been a company that has not made money but is about to break out and make money,” he noted.

On May 1, Sarepta Therapeutics reported better-than-expected first-quarter financial results.

Palantir Technologies Inc. (NYSE:PLTR) is fine, Cramer said. “It's got good commercial and good military.”

On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million.

Price Action:

  • Lazard shares gained 0.4% to settle at $41.16 on Tuesday.
  • Enbridge shares closed at $36.78 on Tuesday.
  • Petroleo Brasileiro shares slipped 0.7% to settle at $15.02.
  • Advanced Drainage System shares gained 1.1% to settle at $179.24 on Tuesday.
  • AST SpaceMobile shares fell 10.8% to settle at $4.71.
  • Zebra Technologies shares gained 0.5% to close at $321.78 on Tuesday.
  • Palantir shares fell 1.8% to close at $21.24.
  • Sarepta Therapeutics shares fell 1.3% to settle at $129.12.
  • Shares of Jacobs Solutions gained 1.4% to close at $ 138.79 during Tuesday's session.
Read Next: Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month

Photo: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.